10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Some new aryl-sydnones: effects on murine tumours.

      Anticancer research
      Animals, Antineoplastic Agents, chemistry, pharmacology, therapeutic use, Blood Cell Count, drug effects, Carcinoma, Ehrlich Tumor, drug therapy, Drug Evaluation, Preclinical, Histiocytoma, Benign Fibrous, Leukemia L1210, Male, Mice, Mice, Inbred DBA, Mice, Inbred Strains, Molecular Structure, Neoplasms, Experimental, Sarcoma 180, Structure-Activity Relationship, Sydnones

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The effects of new aryl-sydnones: 3-[4-X-3-nitrophenyl]-1,2,3-oxadiazolium-5-olates, where X = Cl (SYD-1); pyrrolidino (SYD-2); piperidino (SYD-3) and morpholino (SYD-4) on the survival of mice bearing Sarcoma 180, Ehrlich carcinoma, B10MCII (Fibrous histiocytoma) and L1210 leukemia ascitic tumours, on the proliferation of cultured tumour cells and on the synthesis of DNA in L1210 leukemia were determined. SYD-1 and SYD-2 in vivo significantly enhanced the survival of S180, Ehrilich and B10MCII tumour-bearing mice. Furthermore, SYD-2 showed significant activity against L1210. SYD-3 and SYD-4 did not show antitumour activity. SYD-1, in vitro was the most cytotoxic against all the above tumour cells. All of the drugs tested inhibited thymidine uptake by L1210 cells, SYD-4 being the least active.

          Related collections

          Author and article information

          Comments

          Comment on this article